journal article·2025-05

Protoporphyrin IX conjugated to piperazine or morpholine: Photophysical properties and photodynamic activity

Maynne Duarte Suriani Franco, Thibault Joseph William Jacques Dit Lapierre, Ana Clara Cassiano Martinho, Naiara Cristina Bessas, Mayara Martins Caetano, Thiago Teixeira Tasso, Marcelo Emílio Beletti, Renata Galvão de Lima, Celso de Oliveira Rezende Júnior, Tayana Mazin Tsubone

Dyes and Pigments· Volume 236
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Porphyrin and Phthalocyanine Chemistry · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (82)

Show source-provided references
1. Photodynamic therapy and anti-tumour immunity10.1038/nrc1894 ↗
2. New photosensitizers for photodynamic therapy10.1042/BJ20150942 ↗
3. Photodynamic efficiency: from molecular photochemistry to cell death10.3390/ijms160920523 ↗
4. Porphyrin loaded TyroSpheres for the intracellular delivery of drugs and photo-induced oxidant species10.1021/acs.molpharmaceut.0c00338 ↗
5. Cellular compartments challenged by membrane photo-oxidation10.1016/j.abb.2020.108665 ↗
6. Autophagy regulation and photodynamic therapy: insights to improve outcomes of cancer treatment10.3389/fonc.2020.610472 ↗
7. Upconversion rare Earths nanomaterials applied to photodynamic therapy and bioimaging10.3389/fchem.2022.1035449 ↗
8. Cancer, photodynamic therapy and porphyrin-type derivatives10.1590/0001-3765201820170811 ↗
9. Porphyrin photosensitizers in photodynamic therapy and its applications10.18632/oncotarget.20189 ↗
10. A promising anticancer drug: a photosensitizer based on the porphyrin skeleton10.1039/C9MD00558G ↗
11. Recent advances in the synthesis of piperazine based ligands and metal complexes and their applications10.1039/D0DT03569F ↗
12. Synthesis and in vitro antiproliferative activity of 2-methyl-3-(2- piperazin-1-yl-ethyl)-pyrido[1,2-a]pyrimidin-4-one derivatives against human cancer cell lines10.1007/s12272-012-0105-z ↗
13. Piperazine derivatives for therapeutic use: a patent review (2010-present)10.1080/13543776.2016.1189902 ↗
14. Piperazine scaffold: a remarkable tool in generation of diverse pharmacological agents10.1016/j.ejmech.2015.07.026 ↗
15. Piperazine skeleton in the structural modification of natural products: a review10.1080/14756366.2021.1931861 ↗
16. Synthesis of 5,10,15,20-tetra[4-(N-ethylpiperazinyl)phenyl]-porphyrin and its interaction with DNA10.1002/cjoc.200590431 ↗
17. Chloroalkyl piperazine and nitrogen mustard porphyrins: synthesis and anticancer activity10.1016/j.bmc.2004.01.045 ↗
18. Study on synthesis, characterization and biological activity of some new nitrogen heterocycle porphyrins10.1016/S0968-0896(03)00027-0 ↗
19. Quinacridone derivative as a new photosensitizer: photodynamic effects in cells and in vivo10.1016/j.dyepig.2017.06.003 ↗
20. Novel piperazine-substituted silicon phthalocyanines exert anti-cancer effects against breast cancer cells10.1016/j.pdpdt.2022.102734 ↗
21. Tumor-selective new piperazine-fragmented silicon phthalocyanines initiate cell death in breast cancer cell lines10.1016/j.jphotobiol.2021.112143 ↗
22. Physicochemical and photodynamic antimicrobial chemotherapy activity of morpholine-substituted phthalocyanines: effect of point of substitution and central metal10.1016/j.jphotochem.2019.01.025 ↗
23. DNA interaction and anticancer properties of new peripheral phthalocyanines carrying tosylated 4-morpholinoaniline units10.1016/j.poly.2019.114319 ↗
24. Novel silicon phthalocyanines axially modified by morpholine: synthesis, complexation with serum protein and in vitro photodynamic activity10.1016/j.inoche.2006.02.014 ↗
25. Morpholine as a privileged structure: a review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules10.1002/med.21634 ↗
26. Phthalocyanine derivatives possessing 2-(morpholin-4-yl)ethoxy groups as potential agents for photodynamic therapy10.1021/acs.jmedchem.5b00052 ↗
27. Water soluble axially morpholine disubstituted silicon phthalocyanines: synthesis, characterisation, DNA/BSA binding, DNA photocleavage properties10.1016/j.synthmet.2017.05.006 ↗
28. Photo-physicochemical properties and in vitro photodynamic therapy activity of morpholine-substituted Zinc(II)-Phthalocyanines π-π stacked on biotinylated graphene quantum dots10.1016/j.dyepig.2019.03.002 ↗
29. Valeur · 2012 · 49
30. Lakowicz · 2006 · 1
31. Photophysical properties of protoporphyrin IX, pyropheophorbide-a and photofrin® in different conditions10.3390/ph14020138 ↗
32. The measurement of photoluminescence quantum yields. A review
33. Lakowicz
34. Photosensitized singlet oxygen and its applications10.1016/S0010-8545(02)00034-6 ↗
35. On the use of 1,3-diphenylisobenzofuran (DPBF). Reactions with carbon and oxygen centered radicals in model and natural systems10.1163/156856793X00181 ↗
36. Non-symmetric porphyrins encapsulated in liposomes: tumor cell destruction via non-photodynamic activity10.1016/j.dyepig.2021.109746 ↗
37. The detection sensitivity of commonly used singlet oxygen probes in aqueous environments10.1016/j.jphotobiol.2020.111787 ↗
38. Fluorescence probes used for detection of reactive oxygen species10.1016/j.jbbm.2005.10.003 ↗
39. Chlorophyllin derivatives as photosensitizers: synthesis and photodynamic properties
40. Determination of singlet oxygen quantum yields with 1,3-diphenylisobenzofuran in model membrane systems10.1016/0165-022X(93)90058-V ↗
41. Singlet oxygen generation and spectroscopic properties of supramolecular zinc meso-tetra(4-pyridyl) porphyrin bearing outlying ruthenium groups10.1007/s13538-022-01166-9 ↗
42. Singlet oxygen quantum yields (φΔ) in water using beetroot extract and an array of LEDs10.1590/S0103-50532009000100006 ↗
43. Carbon dots as fluorescent probes for detection of VB12 based on the inner filter effect10.1039/C8RA03070G ↗
44. Characterization of human serum albumin's interactions with safranal and crocin using multi-spectroscopic and molecular docking techniques
45. Enhanced efficiency of cell death by lysosome-specific photodamage10.1038/s41598-017-06788-7 ↗
46. Cell sensitivity assays: the MTT assay
47. Spectra of porphyrins
48. Study of the effects of substitution on the absorption spectra of porphin10.1063/1.1730148 ↗
49. Harris · 1989
50. Photophysical properties of porphyrin derivatives: influence of the alkyl chains in homogeneous and micro-heterogeneous systems10.1142/S1088424615500650 ↗
51. A comparative study of the photosensitizing characteristics of some cyanine dyes10.1016/S1011-1344(00)00021-X ↗
52. A comparative evaluation of the photosensitizing efficiency of porphyrins, chlorins and isobacteriochlorins toward melanoma cancer cells10.3390/molecules28124716 ↗
53. Developments in PDT sensitizers for increased selectivity and singlet oxygen production10.3390/ma8074421 ↗
54. Relationship between structure and photoactivity of porphyrins derived from protoporphyrin IX10.1142/S108842461000263X ↗
55. New platinum(II)–bipyridyl corrole complexes: synthesis, characterization and binding studies with DNA and HSA10.1016/j.jinorgbio.2015.08.016 ↗
56. The synthesis and singlet oxygen generation study of 13(1)-N-piperazinyl chlorin e6-15(2),17(3)-dimethyl ester10.6060/mhc151088b ↗
57. Interactive association of drugs binding to human serum albumin10.3390/ijms15033580 ↗
58. Experimental and computational studies on the binding of diazinon to human serum albumin10.1080/07391102.2017.1329096 ↗
59. J- and H-aggregates of porphyrins with surfactants: fluorescence, stopped flow and electron microscopy studies10.1002/(SICI)1099-1409(199807/10)2:4/5<369::AID-JPP92>3.0.CO;2-3 ↗
60. Experimental and computational characterization of photosensitized conformational effects mediated by protoporphyrin ligands on human serum albumin10.1039/c6pp00096g ↗
61. Protein-aggregating ability of different protoporphyrin-IX nanostructures is dependent on their oxidation and protein-binding capacity10.1016/j.jbc.2021.100778 ↗
62. Characteristics of the protoporphyrin IX binding sites on human serum albumin using molecular docking10.3390/molecules21111519 ↗
63. Effects of photoproducts on the binding properties of protoporphyrin IX to proteins10.1016/S0301-4622(02)00035-2 ↗
64. The effect of porphyrin structure on binding to human serum albumin by fluorescence spectroscopy10.1016/j.jphotochem.2009.08.009 ↗
65. Cellular uptake and photosensitizing properties of anticancer porphyrins in cell membranes and low and high density lipoproteins10.1016/1011-1344(90)85074-7 ↗
66. Accumulation of porphyrins in cells: influence of hydrophobicity aggregation and protein binding10.1111/j.1751-1097.1988.tb02844.x ↗
67. Enhanced cellular uptake and photodynamic effect with amphiphilic fluorinated porphyrins: the role of sulfoester groups and the nature of reactive oxygen species10.3390/ijms21082786 ↗
68. Cellular uptake and photocytotoxicity of glycoconjugated porphyrins in HeLa cells
69. Isomeric effect on the properties of tetraplatinated porphyrins showing optimized phototoxicity for photodynamic therapy10.1039/C7DT01205E ↗
70. Uchoa-Fernandes · 2007
71. A dipyridophenazine Ni(II) dithiolene complex as a dual-acting cancer phototherapy agent activatable within the phototherapeutic window10.1016/j.ejmech.2023.115816 ↗
72. Ocde
73. Phototoxicity: its mechanism and animal alternative test methods10.5487/TR.2015.31.2.097 ↗
74. The international EU/COLIPA in vitro phototoxicity validation study: results of phase II (blind trial)
75. Localization-dependent cell-killing effects of protoporphyrin (PPIX)-lipid micelles and liposomes in photodynamic therapy10.1016/j.bmc.2015.11.001 ↗
76. G-quadruplex DNA/protoporphyrin IX-based synergistic platform for targeted photodynamic cancer therapy10.1016/j.talanta.2014.11.039 ↗
77. Protoporphyrin IX induces apoptosis in HeLa cells prior to photodynamic treatment
78. Cell death induced by photodynamic therapy with the conjugate of gold nanoparticles-PpIX in HeLa cell line10.1063/1.5095911 ↗
79. Effect of photodynamic therapy on proliferation and apoptosis of 3T3 fibroblasts and HeLa cells10.1089/pho.2007.2199 ↗
80. Improved photodynamic effect through encapsulation of two photosensitizers in lipid nanocapsules10.1039/C8TB01759J ↗
81. Tumor suppressor Fhit protein interacts with protoporphyrin IX in vitro and enhances the response of HeLa cells to photodynamic therapy10.1016/j.jphotobiol.2006.08.005 ↗
82. Diamino acid derivatives of PpIX as potential photosensitizers for photodynamic therapy of squamous cell carcinoma and prostate cancer: in vitro studies10.1016/j.jphotobiol.2008.11.005 ↗